Professional Documents
Culture Documents
GU A Y10-20 (U/C Polypyrimidine Tract) AG
GU A Y10-20 (U/C Polypyrimidine Tract) AG
◆
◼ Not the only method to generate different mRNA
- How to regulate?
◼ 1. How to distinguish exon and intron? E.g. Dystrophin gene
◆ Why difficult?
⚫ Introns contain pseudo-exon (appear to be exons but are not
spliced) and cryptic (appear to be authentic splice sites but are
not used)
⚫ Core splice site contain only half of the information
◼ Nucleotide sequences: splicing code
◆ Made by splicing enhancer and splicing silencer sequences embed in
sequence.
◆ Cis-acting
⚫ 5’ss. Branchpoint A, polypyrimidine tract, 3’ss
⚫ splicing enhancer and silencer sequences
◼ ESE(SR), ESS(hnRNPs)
◼ ISE(SR), ISS(hnRNPs)
◼ pseudo-exon: no SE
◆ Transacting splicing regulator: RS, hnRNPs(heterogenous
ribonucleoprotein)
⚫ PTB polypyrimidine track binding protein
⚫ RS: U1, U2, U2AF
⚫ huRNPs: inhibit U1, U2, U2AF
◼ Regulation (tissue specific expression pattern)
◆ Change the expression of transacting splicing regulator
◆ SR: exon inclusion
How to detect?
- RT-PCR
◼ RNA→ DNA
◼
Pre-mRNA 3’end: Cleave and poly A
- Part at 3’ end
◼ Conserved hexamer AAUAAA, poly A signal
◼ GU/CU rich sequence
- Cleave
◼ CA in poly A side
- PolyA
◼ polyA added after CA by PAP(poly A polymerase +200A).
◆ need poly-A-binding protein
⚫ stabilize the poly-A-tail
⚫ bind initiation factors→ translate ()
◼ without poly A
◆ cannot translate
◆ degraded
◼ not in gene
1. Which three snRNPs together make the tri-snRNP particle?